Assessing the current treatment of atopic dermatitis: Unmet needs

Atopic dermatitis (AD) is a complex, chronic, inflammatory, pruritic skin disease managed by allergists and dermatologists. It affects more than 4% of adults and 10% of children, half of whom have persistent skin disease as adults.1,2 Skin barrier dysfunction and inflammation, with concomitant epicutaneous allergen sensitization, opens the door for development of allergic comorbidities, including food allergy, allergic rhinitis, and asthma, in these patients.3 Recent studies have documented the adverse effects of AD on mental health and quality of life.

http://ift.tt/2o9325T